Trial intelligence / Profile preview

Fluconazole for Lymphocutaneous and Visceral Sporotrichosis

NCT00004938Phase 2Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Start
Aug 1996
Modality
Orthosteric Ligands
01

Overview

A Phase 2 trial of fluconazole in sporotrichosis, sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 1996; status: completed.

02

Drugs

fluconazole
03

Conditions

sporotrichosis

Beyond the preview

Go deeper on NCT00004938.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004938.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call